The below technical white papers and application notes are provided by life science tool and service providers. They are not the product of GenomeWeb’s editorial departments.

To submit your white paper or application note please email

To download whitepapers, select those of interest and hit the "next" button at the bottom of the page.

White Paper Search Only

Reducing the variability of pre-analytical handling of biological samples BY BioCision
The increasing use of biomarkers as diagnostic indicators of pathological conditions, as monitors of disease progression or as surrogate markers of patient outcomes in clinical trials has led to a huge increase in the number of biological samples whose accurate analysis is of vital importance...
April 26, 2012

Technical Note: A New Method of Snap Freezing Bacteria Using BioCision’s CoolRack System BY BioCision
The preservation of bacterial cultures by freezing has long been reported (1,2). Several protocols (3,4) recommend snap freezing in glycerol or DMSO prior to storage. One common way to snap freeze is by submerging samples in a slurry of dry ice and ethanol until frozen. BioCision’s CoolRack module...
April 26, 2012

Generating Scientific Insights Through Deep Collaboration BY BioFortis
In order to make data smarter, data exploration tools need to be placed in the hands of not only the IT and informatics experts but also the scientists and domain experts that understand and can act on the data, independent of knowing how to write programming code, the structure of data or even where it is located. The Qiagram deep collaborative environment provides just such tools, allowing researchers to explore their own data in a collaborative, transparent and effective manner.
March 1, 2013

Is Your Biobank Ready for the Challenge of Biomarker-based Research? BY BioFortis
For researchers involved in biomarker-based clinical and translational research, who need to safely and effectively conduct externalized, science-driven collaborative studies, BioFortis’ Next Generation Biobanking software platform harmonizes biospecimen data with clinical and molecular data in a collaborative environment that emphasizes scientific insights, while ensuring security and compliance.
March 1, 2013
Covance Genomics Lab

Impacting Clinical Outcomes: Computational Analysis of Complex Genomics Data Sets BY Covance Genomics Lab
Data analysis, interpretation, and integration of high volumes of multidimensional data are the key to elucidating the mechanism of action of pharmaceutical compounds, understanding the pathways to disease onset and progression, biomarker and target identification. In today's era of large data sets, biopharmaceutical companies are utilizing computational biology to comb through massive sets of genomic data to find links between specific genotypes and diseases, screen drug data to identify therapeutic candidates, as well as identify responders to treatment.
April 16, 2013

Conducting Clinical Next-Generation Sequencing: How to Manage Change, CLIA, NGS and Informatics BY GenoLogics
The drive toward personalized medicine has led many labs to consider conducting clinical tests employing next-generation sequencing, but the decision to do so requires labs to consider how they will conduct this work under the auspices of CLIA or CAP requirements. This paper outlines the general principles of CLIA certification and its specific application to clinical NGS, from the perspective of both research and clinical labs.
January 23, 2014

Increase User Adoption Rates and Realize a Higher Rate of Return on your LIMS Investment BY GenoLogics
Usability is the key to ensuring that LIMS are adopted and used, but many LIMS developers forget about the end user. This paper describes the traditional barriers to LIMS adoption and explains how these hurdles can be overcome by a focus on usability.
January 23, 2014

Reading the Writing on the Wall: Four Telltale Signs That You Might Need a LIMS BY GenoLogics
Many labs shy away from the notion of upgrading to a laboratory information management system because they are happy with spreadsheets, but if your lab is expanding, processing new samples, or offering new services, you may need to upgrade to a more formal or structured solution. This paper poses four questions for labs to determine if it's time to make the leap to a LIMS.
February 19, 2014

Reverse Phase Protein Arrays for Cell Signaling: Using the InnoScan 710-IR scanner improves sensitivity and dynamic range. BY Innopsys
Reverse Phase Protein Arrays (RPPAs) are increasingly used to study cell signaling as they are highly multiplexed and allow precise quantification of protein of interests in biological samples. Such arrays promote automation, simplified work flow, and preserve sample. One of the principal challenges faced by RPPAs is to find the best combination of an array surface that will support high binding levels of viable protein probes, and a detection method that will provide high sensitivity and dynamic range. With the new InnoScan 710-IR scanner it is now possible to combine infrared detection with high sensitivity and quality images.
May 22, 2013

Infrared detection decreases nitrocellulose autofluorescence and improves RPPA assays signal‐to‐noise ratio over visible wavelength detection BY Innopsys
Advances in RPPA and more generally protein array technology have resulted in a rapidly growing market. Besides RPPAs there are also analytical and functional protein microarrays. Protein array applications in disease biomarker discovery and validation reflect the enormous potential of protein arrays in the field of personalized medicine. Until now the rise of protein array technology was limited by high fluorescence emitted by nitrocellulose. The InnoScan 710-IR infrared microarray scanner now allows an increased Signal to Noise Ratio and thus sensitivity of RPPAs by decreasing background fluorscence. In addition, with a high resolution of up to 3µm per pixel, it allows the acquisition of high quality images.
August 12, 2013

High Throughput RT-qPCR for Gene Expression Analysis BY Labcyte
The current standard of accuracy for quantification of gene expression is reverse transcriptase quantitative PCR (RT-qPCR). A new, cost-effective sample preparation method for RT-PCR incorporates a “one-step” cell lysis buffer which eliminates the need for mRNA isolation and purification. This improved method, when combined with nanoscale non-contact liquid handling technology enables a high throughput automated workflow for gene expression.
August 2, 2013

Automated RT-qPCR Utilizing the Access™ Workstation, the Echo® Liquid Handler, and RealTime Ready™ Reagents from Roche Applied Science BY Labcyte
RT-qPCR has been increasingly utilized by researchers to quantify mRNA levels. Its widespread use has been limited by an often laborious multi-step process and high reagent cost. Recent advances in non-contact reagent dispensing and next generation one step lysis reagents are enabling scientists to generate high throughput data at a much faster rate. This technical note describes the automation of three complementary tools to generate high throughout RT-qPCR data; the Echo liquid handler, RealTime Ready cell lysis reagents, and the Access workstation.
August 2, 2013

High-throughput Miniaturized Quantitative PCR with the Echo® 525 Liquid Handler BY Labcyte
Quantitative PCR (qPCR) is a prevalent tool spanning many phases of drug discovery. Advances in qPCR detection to enable 384- and 1536-well microplate formats have incentivized researchers to miniaturize qPCR assays as a means to offset the costs of increasing throughput. To significantly reduce qPCR volumes and maintain data quality, the liquid handling methods employed for such low-volume transfers must be precise and accurate. Tipless, touchless acoustic droplet ejection with the Echo liquid handler eliminates the cost of disposable tips or tip-wash cycles and simplifies assay setup by eliminating dilution steps. This study utilized the Echo 525 liquid handler to assemble low-volume qPCR assays at speeds that keep pace with high-throughput demands. The results demonstrated the Echo 525 liquid handler effectively miniaturized reaction volumes for high-throughput qPCR in both 384- and 1536-well formats.
August 2, 2013

Miniaturizing siRNA Transfection Using the Echo® Liquid Handler BY Labcyte
Large-scale, high-throughput siRNA experiments require a transfer system that can facilitate reliable and reproducible transfections in high-density well-plate formats, as well as effective delivery of the siRNA molecule. This study demonstrates superior performance of the Echo liquid handler compared to more traditional liquid handling methods for standard, reverse and lipid-free transfection of siRNA molecules into mammalian cells. Results of the study clearly demonstrate the ability of the Echo liquid handler to deliver comparable transfection efficiency, knock-down and cell morphology to reactions prepared using traditional pipeting methods. In fact, reactions prepared with the Echo liquid handler were miniaturized to use significantly less volume of siRNA and other reagents, and still yielded more representative inclusion intensities than traditional manual pipetting techniques. Such miniaturization can result in significant cost savings and greater confidence in the results from siRNA screening studies.
August 2, 2013

Miniaturization of the KASP™ Genotyping Assay for Maize with the Echo 525 Liquid Handler BY Labcyte
SNP genotyping of maize samples is commonly performed in agricultural science to aide marker assisted selection, study heterosis and a variety of biological behaviors. Its widespread adoption in agricultural science has been challenged with increasing reagent costs and labor intensive multi-step processes. Acoustic non-contact liquid handling using the Echo 525 liquid handler offers unique advantages to traditional processes by incorporating a tip-less solution to deliver reagents precisely and accurately. Assay miniaturization is enabled with high accuracy and precision at volumes as low as 25nL. This study utilized the Echo 525 liquid handler to miniaturize a KASP genotyping assay for maize at a throughput meeting the demands of most high throughput production processes.
September 26, 2013

RNAi Screening in Primary Cells BY Lonza
Screening approaches involving either overexpression or RNAi-mediated down-regulation of genes have become a potent tool for identifying drug targets. Such screens require transfection of cells with e.g. cDNA or shRNA vectors or siRNA oligonucleotides. One important factor for screening success is the ability to efficiently transfect biologically relevant cells. Lonza’s Nucleofector™ Technology is a proven non-viral method for efficient transfection of primary cells, e.g. human T cells. The HT Nucleofector™ System, a 384-well platform, expands its application range to high-throughput transfections. With its fast plate processing time and easy integration into liquid handling systems it is a convenient tool for siRNA, shRNA or miRNA screens in biologically relevant cell types.
July 29, 2013

Oracle Health Sciences Translational Research Center: A Translational Medicine Platform to Address the Big Data Challenge BY Oracle
Oracle Health Sciences Translational Research Center is a scalable informatics solution for translational research. Its back-end data components seamlessly integrate clinical and omics data from diverse clinical data sources as well as from vendor-specific and modality-specific omics data silos, providing standardized data readily available for the front-end application.
February 4, 2013
Sage Science

Scientists Use Pippin to Optimize Nextera Libraries BY Sage Science
Learn how Pippin Prep can optimize your Nextera libraries In this case study, Zach Herbert at the Dana-Farber Cancer Institute describes adding automated DNA sizing from Sage Science to his Nextera workflow for better sequence results.
March 7, 2014

Precise Sizing and SMRT Sequencing Offer Unprecedented Read Length for Clinical Studies BY Sage Science
Using BluePippin significantly extends average read length for PacBio. Read this case study to learn how Robert Sebra at the Icahn Institute for Genomics and Multiscale Biology uses automated DNA size selection to maximize read length with SMRT Sequencing.
March 7, 2014

Rapid and Simple Isolation of Circulating Tumor Cells for Clinical and Research Applications Using ScreenCell® BY ScreenCell
Circulating Tumor Cells (CTCs) are associated with diminished survival for cancer patients. Simple enumeration of CTCs is not enough: characterization of CTCs from each case is vital for development of new therapies. New assay capability for cytology-based, FISH, PCR, whole genome sequencing and other critical tests require immediate CTCs separated from other blood components - within minutes. Read how...
April 8, 2014

Cookie Cutter Proteolysis: Achieving Reproducible, Efficient Digestions for Proteomic Workflows BY Shimadzu
Protein sample preparation workflows for mass spectrometric analysis that involve proteolysis are often labor-intensive, time consuming, and user dependent. The introduction of variability hinders discovery initiatives. Recently, an automated protein digestion platform was developed that accelerates the digestion process while providing exceptional reproducibility. As demonstrated in this poster, it offers complete, reproducible protein digestions in as little as 30 seconds, allowing hundreds of samples to be run per day, and can be adapted to many applications.
July 24, 2013